New Drug Application News and Research

RSS
FDA approves immune-modulating therapy for treatment of multiple sclerosis

FDA approves immune-modulating therapy for treatment of multiple sclerosis

New clinical trial uses universal natural killer cell approach to treat acute myeloid leukemia

New clinical trial uses universal natural killer cell approach to treat acute myeloid leukemia

Mayo Clinic researchers seek radical new approach to treat cocaine addition

Mayo Clinic researchers seek radical new approach to treat cocaine addition

GB Sciences announces preclinical results of promising formulations for Parkinson's disease

GB Sciences announces preclinical results of promising formulations for Parkinson's disease

Treatment combination improves survival in advanced HER2-positive breast cancer patients

Treatment combination improves survival in advanced HER2-positive breast cancer patients

Experimental drug better for repeat kidney cancer patients than FDA-approved equivalent

Experimental drug better for repeat kidney cancer patients than FDA-approved equivalent

Three UCLA researchers receive multimillion-dollar grant from state's stem cell agency

Three UCLA researchers receive multimillion-dollar grant from state's stem cell agency

Failed cancer drug could potentially be used to treat fibrotic diseases and scleroderma

Failed cancer drug could potentially be used to treat fibrotic diseases and scleroderma

Many drug manufacturers fail to complete the FDA approval process, research reveals

Many drug manufacturers fail to complete the FDA approval process, research reveals

Finding innovative treatments to help patients with traumatic brain injury

Finding innovative treatments to help patients with traumatic brain injury

FDA clears its IND for new immunotherapeutic for treating prostate cancer

FDA clears its IND for new immunotherapeutic for treating prostate cancer

SCYNEXIS announces positive results from first interim efficacy analysis of FURI study

SCYNEXIS announces positive results from first interim efficacy analysis of FURI study

UC San Diego to conduct first U.S. clinical trial of intravenously administered bacteriophage therapy

UC San Diego to conduct first U.S. clinical trial of intravenously administered bacteriophage therapy

FDA warns Genetech for marketing stem cell products without approval

FDA warns Genetech for marketing stem cell products without approval

RNAi therapy shown to alleviate preeclampsia in animal model

RNAi therapy shown to alleviate preeclampsia in animal model

Phase III CLL14 study evaluating Venclexta plus Gazyva to treat CLL meets its primary endpoint

Phase III CLL14 study evaluating Venclexta plus Gazyva to treat CLL meets its primary endpoint

IU Philanthropic Venture Fund commits to invest $500,000 to NERx Biosciences company

IU Philanthropic Venture Fund commits to invest $500,000 to NERx Biosciences company

The Lancet Infectious Diseases journal publishes clinical trial results for Shionogi’s cefiderocol

The Lancet Infectious Diseases journal publishes clinical trial results for Shionogi’s cefiderocol

Incyte announces Phase 2 FIGHT-202 trial data in patients with cholangiocarcinoma

Incyte announces Phase 2 FIGHT-202 trial data in patients with cholangiocarcinoma

Scientists receive $5.1 million grant to develop stem cell-based therapy for blinding retinal conditions

Scientists receive $5.1 million grant to develop stem cell-based therapy for blinding retinal conditions